KRYS vs MTD · P/E 46, rev $235.6M vs P/E 27, rev $1.97B
Krystal Biotech Inc (KRYS) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Krystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported KRYS revenue for 2026-06-30 was $235.6M. Net income was $110.7M. KRYS currently screens at market cap $10.17B and trailing P/E 46.1.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
KRYS currently screens at market cap $10.17B and trailing P/E 46.1. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the KRYS and MTD stock pages for the full models.
Not investment advice.